These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26785154)

  • 41. A Systematic Review of NMDA Receptor Antagonists for Treatment of Neuropathic Pain in Clinical Practice.
    Aiyer R; Mehta N; Gungor S; Gulati A
    Clin J Pain; 2018 May; 34(5):450-467. PubMed ID: 28877137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An investigation of factors contributing to higher levels of placebo response in clinical trials in neuropathic pain: a systematic review and meta-analysis.
    Arakawa A; Kaneko M; Narukawa M
    Clin Drug Investig; 2015 Feb; 35(2):67-81. PubMed ID: 25559268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
    Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.
    Backonja M; Glanzman RL
    Clin Ther; 2003 Jan; 25(1):81-104. PubMed ID: 12637113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NMDA receptor antagonists for the treatment of neuropathic pain.
    Collins S; Sigtermans MJ; Dahan A; Zuurmond WW; Perez RS
    Pain Med; 2010 Nov; 11(11):1726-42. PubMed ID: 21044263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hydromorphone for neuropathic pain in adults.
    Stannard C; Gaskell H; Derry S; Aldington D; Cole P; Cooper TE; Knaggs R; Wiffen PJ; Moore RA
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD011604. PubMed ID: 27216018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NS1209/SPD 502, A Novel Selective AMPA Antagonist for Stroke, Neuropathic Pain or Epilepsy? Drug Development Lessons Learned.
    Keppel Hesselink JM
    Drug Dev Res; 2017 Mar; 78(2):75-80. PubMed ID: 28195646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hydromorphone extended release for neuropathic and non-neuropathic/nociceptive chronic low back pain: a post hoc analysis of data from a randomized, multicenter, double-blind, placebo-controlled clinical trial.
    Nalamachu S; Hale M; Khan A
    J Opioid Manag; 2014; 10(5):311-22. PubMed ID: 25350473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial.
    Stacey BR; Dworkin RH; Murphy K; Sharma U; Emir B; Griesing T
    Pain Med; 2008 Nov; 9(8):1202-8. PubMed ID: 18346060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxcarbazepine for neuropathic pain.
    Zhou M; Chen N; He L; Yang M; Zhu C; Wu F
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007963. PubMed ID: 23543558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trial.
    Markman J; Resnick M; Greenberg S; Katz N; Yang R; Scavone J; Whalen E; Gregorian G; Parsons B; Knapp L
    J Neurol; 2018 Dec; 265(12):2815-2824. PubMed ID: 30242745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic administration of local anesthetic agents to relieve neuropathic pain.
    Challapalli V; Tremont-Lukats IW; McNicol ED; Lau J; Carr DB
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study.
    Ostenfeld T; Krishen A; Lai RY; Bullman J; Baines AJ; Green J; Anand P; Kelly M
    Eur J Pain; 2013 Jul; 17(6):844-57. PubMed ID: 23239139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms and treatment of neuropathic pain.
    Vranken JH
    Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):71-8. PubMed ID: 20021340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials.
    Onakpoya IJ; Thomas ET; Lee JJ; Goldacre B; Heneghan CJ
    BMJ Open; 2019 Jan; 9(1):e023600. PubMed ID: 30670513
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of minocycline on lumbar radicular neuropathic pain: a randomized, placebo-controlled, double-blind clinical trial with amitriptyline as a comparator.
    Vanelderen P; Van Zundert J; Kozicz T; Puylaert M; De Vooght P; Mestrum R; Heylen R; Roubos E; Vissers K
    Anesthesiology; 2015 Feb; 122(2):399-406. PubMed ID: 25373391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review.
    Hempenstall K; Nurmikko TJ; Johnson RW; A'Hern RP; Rice AS
    PLoS Med; 2005 Jul; 2(7):e164. PubMed ID: 16013891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain.
    Wallace MS; Rowbotham MC; Katz NP; Dworkin RH; Dotson RM; Galer BS; Rauck RL; Backonja MM; Quessy SN; Meisner PD
    Neurology; 2002 Dec; 59(11):1694-700. PubMed ID: 12473754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropathic pain: preclinical and early clinical progress with voltage-gated sodium channel blockers.
    Kushnarev M; Pirvulescu IP; Candido KD; Knezevic NN
    Expert Opin Investig Drugs; 2020 Mar; 29(3):259-271. PubMed ID: 32070160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.